DV1 is a selective antagonist of the CXC chemokine receptor 4 (CXCR4). It demonstrates antiviral activity by blocking HIV-1 entry via the CXCR4 co-receptor. Additionally, DV1 is stable in rat plasma and exhibits favorable pharmacokinetic properties in rat models.
Formel:
C108H170N34O26S2
Target-Kategorie:
HIV Protease|||CXCR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
